Alessandro Santin, MD, received the Yale Cancer Center Clinical Science Research Prize at this year’s YCC Annual Conclave for his paper, Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu, in the Journal of Clinical Oncology. The award was presented by Peter Schwartz, MD.
Submitted by Emily Montemerlo on January 11, 2019